- Title
- Effect of Baseline or Changes in Adrenergic Activity on Clinical Outcomes in the β-Blocker Evaluation of Survival Trial
- Creators
- M.R Bristow - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanH Krause-Steinrauf - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanR Nuzzo - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanCheng-Seng Liang - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanJ Lindenfeld - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanB.D Lowes - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanB Hattler - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanW.T Abraham - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanL Olson - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanS Krueger - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanS Thaneemit-Chen - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanJ.M Hare - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanH.S Loeb - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanM.J Domanski - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanE.J Eichhorn - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanR Zelis - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); BryanP Lavori - From the University of Colorado Health Sciences Center, Division of Cardiology, Denver, Colo (M.R.B., J.L., B.D.L., B.H., E.J.E.); National Heart, Lung, and Blood Institute, Palo Alto, Calif (H.K.-S., M.J.D.); Division of Cardiology, Stanford University, Stanford, Calif (R.N.); Cardiology, University of Rochester, Rochester, NY (C.-S.L.); Physiology and Cell Biology, Ohio State University, Columbus (W.T.A.); Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, Minn (E.O.); Bryan
- Publication Details
- Circulation (New York, N.Y.), Vol.110(11), pp.1437-1442
- Academic Unit
- Leadership Department; Miller School of Medicine; Interdisciplinary Stem Cell Institute
- Language
- English
- Resource Type
- Journal article
- PMID
- 15337700
- Record Identifier
- 991031561992202976
Journal article
Effect of Baseline or Changes in Adrenergic Activity on Clinical Outcomes in the β-Blocker Evaluation of Survival Trial
Circulation (New York, N.Y.), Vol.110(11), pp.1437-1442
2004-09-14
PMID: 15337700
Metrics
12 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.37 Cardiology - General
- 1.37.328 Heart Failure
- Web Of Science research areas
- Cardiac & Cardiovascular Systems
- Peripheral Vascular Disease
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites